Fig. 1From: Assessment of efficacy and safety of two Egyptian protocols for treatment-experienced HCV patients: an observational studyFlow chart of patients’ recruitment and enrolment in the study. SVR12, sustained virological response; IFN, interferon; SOF, sofosbuvir; DCV, daclatasvir; SMV, simeprevir; RBV, ribavirin; PTV, paritaprevir; OMB, ombitasvir; RTV, ritonavir, Gp, treatment groupBack to article page